202 related articles for article (PubMed ID: 28081259)
1. Frequency of Propionibacterium acnes Infection in Prostate Glands with Negative Biopsy Results Is an Independent Risk Factor for Prostate Cancer in Patients with Increased Serum PSA Titers.
Kakegawa T; Bae Y; Ito T; Uchida K; Sekine M; Nakajima Y; Furukawa A; Suzuki Y; Kumagai J; Akashi T; Eishi Y
PLoS One; 2017; 12(1):e0169984. PubMed ID: 28081259
[TBL] [Abstract][Full Text] [Related]
2. Intracellular Propionibacterium acnes infection in glandular epithelium and stromal macrophages of the prostate with or without cancer.
Bae Y; Ito T; Iida T; Uchida K; Sekine M; Nakajima Y; Kumagai J; Yokoyama T; Kawachi H; Akashi T; Eishi Y
PLoS One; 2014; 9(2):e90324. PubMed ID: 24587325
[TBL] [Abstract][Full Text] [Related]
3. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men.
Shannon BA; Cohen RJ; Garrett KL
BJU Int; 2008 Feb; 101(4):429-35. PubMed ID: 17850358
[TBL] [Abstract][Full Text] [Related]
4. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution?
Cohen RJ; Shannon BA; McNeal JE; Shannon T; Garrett KL
J Urol; 2005 Jun; 173(6):1969-74. PubMed ID: 15879794
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells.
Fassi Fehri L; Mak TN; Laube B; Brinkmann V; Ogilvie LA; Mollenkopf H; Lein M; Schmidt T; Meyer TF; Brüggemann H
Int J Med Microbiol; 2011 Jan; 301(1):69-78. PubMed ID: 20943438
[TBL] [Abstract][Full Text] [Related]
6. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
7. Propionibacterium acnes infection associated with cancerous prostate hypertrophy.
Olender A; Radej S; Płaza P; Bar K; Maciejewski R
Pol Arch Med Wewn; 2016 Sep; 126(9):697-699. PubMed ID: 27629109
[No Abstract] [Full Text] [Related]
8. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
9. Multilocus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens.
Mak TN; Yu SH; De Marzo AM; Brüggemann H; Sfanos KS
Prostate; 2013 May; 73(7):770-7. PubMed ID: 23184509
[TBL] [Abstract][Full Text] [Related]
10. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
[TBL] [Abstract][Full Text] [Related]
11. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
[TBL] [Abstract][Full Text] [Related]
12. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
13. A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.
Shinohara DB; Vaghasia AM; Yu SH; Mak TN; Brüggemann H; Nelson WG; De Marzo AM; Yegnasubramanian S; Sfanos KS
Prostate; 2013 Jun; 73(9):1007-15. PubMed ID: 23389852
[TBL] [Abstract][Full Text] [Related]
14. Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.
Lazzeri M; Haese A; Abrate A; de la Taille A; Redorta JP; McNicholas T; Lughezzani G; Lista G; Larcher A; Bini V; Cestari A; Buffi N; Graefen M; Bosset O; Le Corvoisier P; Breda A; de la Torre P; Fowler L; Roux J; Guazzoni G
BJU Int; 2013 Aug; 112(3):313-21. PubMed ID: 23826841
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy.
Xie GS; Lyv JX; Li G; Yan CY; Hou JQ; Pu JX; Ding X; Huang YH
Chin Med J (Engl); 2016 Aug; 129(15):1800-4. PubMed ID: 27453228
[TBL] [Abstract][Full Text] [Related]
16. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
[TBL] [Abstract][Full Text] [Related]
17. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
[TBL] [Abstract][Full Text] [Related]
18. A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy.
Zhang W; Ren SC; Shi XL; Liu YW; Zhu YS; Jing TL; Wang FB; Chen R; Xu CL; Wang HQ; Wang HF; Wang Y; Liu B; Li YM; Fang ZY; Guo F; Lu X; Shen D; Gao X; Hou JG; Sun YH
Prostate; 2015 May; 75(6):653-61. PubMed ID: 25597901
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
[TBL] [Abstract][Full Text] [Related]
20. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
Shao Q; Song J; Zhou ZJ; Du LD
Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
